No Data
No Data
No Data
No Data
No Data
Promising Phase 1 Results for Terns Pharmaceuticals' TERN-701 Bolster Buy Recommendation
TipRanks53minutes ago
Terns Pharmaceuticals Price Target Maintained With a $5.50/Share by HC Wainwright & Co.
Terns Pharmaceuticals Price Target Maintained With a $5.50/Share by HC Wainwright & Co.
Dow JonesApr 30 12:56 ET
Express News | JMP Securities Reiterates Market Outperform on Terns Pharma, Maintains $15 Price Target
BenzingaApr 30 12:18 ET
Terns Pharma Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 04/30/2024 202.42% JMP Securities → $15 Reiterates Market Outperform → Market Outperform 03/27/2024 262.9%
BenzingaApr 30 12:17 ET
Market Outperform Rating for Terns Pharmaceuticals With a $15 Price Target Based on TERN-701's Strong Clinical Profile
TipRanksApr 30 00:25 ET
Terns Pharmaceuticals Reveals Encouraging TERN-701 Study Data
TipRanksApr 29 16:33 ET
No Data
No Data